Northern Trust’s NeuroOne Medical Technologies NMTC Stock Holding History

Northern Trust’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$87.1K	Hold	18,687	–	–	﹤0.01%	4136
2025 Q4	$85K	Hold	18,687	–	–	﹤0.01%	4166
2025 Q3	$99.6K	Buy	18,687 +10,525	+129%	+$51.5K	﹤0.01%	4139
2025 Q2	$33.2K	Hold	8,162	–	–	﹤0.01%	4296
2025 Q1	$41.6K	Buy	8,162 +3,115	+62%	+$19.8K	﹤0.01%	4252
2024 Q4	$25K	Hold	5,047	–	–	﹤0.01%	4357
2024 Q3	$30K	Hold	5,047	–	–	﹤0.01%	4285
2024 Q2	$24.2K	Hold	5,047	–	–	﹤0.01%	4314
2024 Q1	$36.3K	Hold	5,047	–	–	﹤0.01%	4270
2023 Q4	$47.8K	Buy	5,047 +1,725	+52%	+$12.7K	﹤0.01%	4245
2023 Q3	$17.7K	Hold	3,322	–	–	﹤0.01%	4350
2023 Q2	$23.9K	Hold	3,322	–	–	﹤0.01%	4372
2023 Q1	$32.1K	Hold	3,322	–	–	﹤0.01%	4365
2022 Q4	$23.9K	Buy	3,322 +759	+30%	+$6.79K	﹤0.01%	4454
2022 Q3	$26K	Hold	2,563	–	–	﹤0.01%	4499
2022 Q2	$13K	Hold	2,563	–	–	﹤0.01%	4673
2022 Q1	$17K	Hold	2,563	–	–	﹤0.01%	4680
2021 Q4	$30K	Buy	+2,563	New	+$41.5K	﹤0.01%	4668

Other funds holding NMTC

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Northern Trust's NMTC Position: Q1 2026 in Review

Northern Trust held its NeuroOne Medical Technologies (NMTC) position steady in Q1 2026 at 18,687 shares worth $87.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4136.

Northern Trust first reported a position in NMTC in Q4 2021 and has held it in 18 quarters since. The position peaked at $99.6K in Q3 2025. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

Northern Trust held 18,687 shares of NeuroOne Medical Technologies worth $87.1K as of Q1 2026.
Northern Trust left its NeuroOne Medical Technologies share count unchanged in Q1 2026.
NeuroOne Medical Technologies made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4136 holding.
Northern Trust first reported a position in NeuroOne Medical Technologies in Q4 2021 and has held it in 18 quarters since.
Northern Trust's NeuroOne Medical Technologies position peaked at $99.6K in Q3 2025.
32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.